Insider · CIK 0001709033
Rajiv Shukla
Files at XAGE (Carmell Corp). First filing Nov 21, 2023, latest Dec 4, 2023.
In brief
Rajiv Shukla files SEC Form 4 as CEO, chair, director and 10% owner at XAGE (Carmell Corp). Since Nov 21, 2023, Rajiv Shukla has reported 3 open-market buys worth $71k and 0 open-market sells worth $0, the latest filed on Dec 4, 2023.
A track record needs three past buys with six months of prices behind them; Rajiv Shukla has 0, so none is measured yet.
The newest scored trade: bought $38k of XAGE on Nov 28, 2023, filed Dec 4, 2023, scored 69 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XAGE: Carmell Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 69Notable | Carmell Corp | $38k 13,617 shares | +66% | +68% from low-74% from high | |
| 59Moderate | Carmell Corp | $18k 6,000 shares | +41% | +58% from low-76% from high | |
| 51Moderate | Carmell Corp | $16k 5,950 shares | +69% | +31% from low-80% from high |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | XAGE Carmell Corp | AGrant or award Stock Option (right to buy)derivative | +876,878 | $0.00 | $0 | 876,878 | Nov 8, 2024 |
| Nov 28, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +2,501 | $2.92 | $7,303 | 23,063 | Dec 4, 2023 |
| Nov 29, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +5,014 | $2.91 | $15k | 28,077 | Dec 4, 2023 |
| Nov 30, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +5,600 | $2.66 | $15k | 33,677 | Dec 4, 2023 |
| Dec 1, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +502 | $2.50 | $1,255 | 34,179 | Dec 4, 2023 |
| Jul 26, 2021 | XAGE Carmell Corp | JOther Common Stockindirect: By AHAC Sponsor III LLC | +0 | $0.00 | $0 | 4,249,908 | Dec 4, 2023 |
| Nov 22, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +1,185 | $2.78 | $3,291 | 15,747 | Nov 28, 2023 |
| Nov 24, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +2,715 | $2.95 | $7,999 | 18,462 | Nov 28, 2023 |
| Nov 27, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +2,100 | $2.97 | $6,247 | 20,562 | Nov 28, 2023 |
| Jul 26, 2021 | XAGE Carmell Corp | JOther Common Stockindirect: By AHAC Sponsor III LLC | +0 | $0.00 | $0 | 4,249,908 | Nov 28, 2023 |
| Nov 17, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +2,000 | $2.69 | $5,380 | 10,612 | Nov 21, 2023 |
| Nov 20, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +3,750 | $2.62 | $9,817 | 14,362 | Nov 21, 2023 |
| Nov 21, 2023 | XAGE Carmell Corp | POpen-market purchase Common Stock | +200 | $2.49 | $497 | 14,562 | Nov 21, 2023 |
| Jul 26, 2021 | XAGE Carmell Corp | JOther Common Stockindirect: By AHAC Sponsor III LLC | +0 | $0.00 | $0 | 4,249,908 | Nov 21, 2023 |
Questions about Rajiv Shukla
Answered from the filings on this page, as of the latest one.
Is Rajiv Shukla buying or selling?
Not in the last 12 months. Rajiv Shukla's latest open-market trade on SEC Form 4 was bought $38k of XAGE on Nov 28, 2023.
How did Rajiv Shukla's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rajiv Shukla has 0.
Where does Rajiv Shukla file Form 4?
Rajiv Shukla has filed Form 4 at XAGE (Carmell Corp) as Chairman and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.